L-carnitine prevents progression of non-alcoholic steatohepatitis in a mouse model with upregulation of mitochondrial pathway.
Non-alcoholic steatohepatitis (NASH) is a severe form of non-alcoholic fatty liver disease characterized by lobular inflammation, hepatocellular ballooning, and fibrosis with an inherent risk for progression to cirrhosis and hepatocellular carcinoma (HCC). Mitochondrial dysfunction appears to play a...
Main Authors: | Hisashi Ishikawa, Akinobu Takaki, Ryuichiro Tsuzaki, Tetsuya Yasunaka, Kazuko Koike, Yasuyuki Shimomura, Hiroyuki Seki, Hiroshi Matsushita, Yasuhiro Miyake, Fusao Ikeda, Hidenori Shiraha, Kazuhiro Nouso, Kazuhide Yamamoto |
---|---|
Format: | Article |
Language: | English |
Published: |
Public Library of Science (PLoS)
2014-01-01
|
Series: | PLoS ONE |
Online Access: | http://europepmc.org/articles/PMC4077577?pdf=render |
Similar Items
-
Serum glycan markers for evaluation of disease activity and prediction of clinical course in patients with ulcerative colitis.
by: Koji Miyahara, et al.
Published: (2013-01-01) -
Hepatitis B virus core promoter mutations G1613A and C1653T are significantly associated with hepatocellular carcinoma in genotype C HBV-infected patients
by: Fujioka Shin-Ichi, et al.
Published: (2011-10-01) -
Molecular Mechanisms to Control Post-Transplantation Hepatitis B Recurrence
by: Akinobu Takaki, et al.
Published: (2015-07-01) -
A preliminary study for constructing a bioartificial liver device with induced pluripotent stem cell-derived hepatocytes
by: Iwamuro Masaya, et al.
Published: (2012-12-01) -
The efficacy of L-carnitine in patients with nonalcoholic steatohepatitis and concomitant obesity
by: Natalia Zakharova, et al.
Published: (2023-07-01)